Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Common Equity (2015 - 2026)

Immuron (IMRN) posted Common Equity of $11.0 million for Q3 2026, up 36.4% on a QoQ basis from $8.1 million in Q4 2025, and up 13603.38% year-over-year from N/an in Q3 2025.

Analysis

Immuron (IMRN) Common Equity (2015 - 2026) Analysis & Trends

Immuron has reported Common Equity for 12 years, with the latest figure at $11.0 million in Q3 2026.

  • On a quarterly basis, Common Equity rose 13603.38% year-over-year to $11.0 million in Q3 2026; TTM through Aug 2026 was $11.0 million, a 13603.38% increase from a year earlier, with the FY2026 full-year figure at $11.0 million, up 13603.38% from the prior year.
  • Common Equity was $11.0 million for Q3 2026 at Immuron, up from $8.1 million in the prior quarter.
  • The five-year high for Common Equity was $16.6 million in Q2 2022, with the low at $80318.3 in Q3 2025.
  • Average Common Equity over 5 years is $9.1 million, with a median of $9.7 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2026: Common Equity plunged 98.78% in 2023, then soared 13603.38% in 2026.
  • Over 5 years, Common Equity stood at $15.2 million in 2022, then declined by 16.14% to $12.8 million in 2023, then sank by 34.92% to $8.3 million in 2024, then slipped by 2.92% to $8.1 million in 2025, then jumped by 36.4% to $11.0 million in 2026.
  • The last three Common Equity figures came in at $11.0 million (Q3 2026), $8.1 million (Q4 2025), and $80318.3 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 11.69 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 11.83 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 20.25 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 31.71 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 8.42 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 6.76 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.35 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 18.85 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 4.92 Bn
10 Immuron 10.28 Mn 1.26 Mn - 11.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 11.01 Mn
Dec 31, 2025 8.07 Mn
Sep 2, 2025 80,318.33
Jun 30, 2025 5.17 Mn
Dec 31, 2024 8.31 Mn
Sep 9, 2024 84,687.47
Jun 30, 2024 8.38 Mn
Dec 31, 2023 12.77 Mn
Sep 28, 2023 12.86 Mn
Aug 30, 2023 196,168.36
Jun 30, 2023 13.11 Mn
Dec 31, 2022 15.23 Mn
Aug 31, 2022 16.12 Mn
Jun 30, 2022 16.60 Mn
Dec 31, 2021 18.96 Mn
Sep 30, 2021 19.04 Mn
Jun 30, 2021 19.94 Mn
Dec 31, 2020 4.13 Mn
Sep 1, 2020 62.43 Mn
Jun 30, 2020 3.70 Mn